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Abstract
Background-In patients with drug resistant incessant supraventricular tachycardia, radiofrequency induced ablation of the atrioventricular junction and pacemaker implantation have hitherto been considered a treatment of last resort. Objective-To assess the short and long term effects of ablation of the atrioventricular junction on systolic and diastolic left ventricular function in patients with atrial fibrillation with and without impaired left ventricular function. Patients-29 patients (19 men; mean age 65 (SD 7) years (range 50-76)) undergoing ablation of the atrioventricular junction for drug refractory atrial fibrillation were examined a mean of 2, 65, and 216 days after ablation of the bundle of His. Main outcome measures-Left ventricular ejection fraction and early filling deceleration times (Edec) were assessed by Doppler echocardiography after 1 to 2 hours of ventricular pacing at a rate of 80 beatsiminute. Results-In 14 patients with a left ventricular ejection fraction < 50% left ventricular ejection fraction increased significantly from 32% (11%) to 39% (11%) (65 days) and 45% (11%) (216 days) (P < 0.001); Edec increased from 142 (46) ms to 169 (57) ms (65 days) and 167 (56) ms (216 days) (P < 0-05). In 15 patients with an ejection fraction > 50% at the initial examination no significant change in systolic function was observed. Conclusions-In patients with left ventricular dysfunction long term improvement of systolic and diastolic left ventricular function was seen after ablation of the atrioventricular junction for rate control of atrial fibrillation. This procedure had no adverse effects on normal left ventricular function. Left ventricular dysfunction and congestive heart failure may develop as a consequence of incessant tachycardia. In the clinical setting this has been observed especially in children and newborn infants.' 2 In adult patients with left ventricular dysfunction and atrial tachycardias, mostly atrial fibrillation, a causal relation is often obscure but highly likely.3 5 In selected cases direct current conversion or rate regulation by pharmacological treatment has been followed by improvement in systolic left ventricular function.6 However, prophylactic drug treatment after direct current conversion or to regulate the heart rate in chronic atrial fibrillation usually has negative inotropic effects, with the exception of digoxin and possibly amiodarone. Furthermore, such treatment sometimes fails or is intolerable. As an alternative, ablation of the atrioventricular junction has been introduced, initially using direct current shocks7 8 and subsequently radiofrequency energy.9 '0 This treatment may also improve systolic function in patients with left ventricular dysfunction, at least in the short term of six weeks." '1 The long term effects, the effects on the sensitive diastolic function, and the effects on the normal left ventricle are unknown.
This prospective study was designed to assess the short and long term effects of radiofrequency ablation of the atrioventricular junction and pacemaker implantation on systolic and diastolic left ventricular function in patients with atrial fibrillation with and without impaired left ventricular function.
Patients and methods
Twenty nine patients (19 men) with a mean age of 65 (SD 7) years (range 50-76) were included. The patients had chronic or paroxysmal atrial fibrillation, and they had on average tried 3-7 (2-7) different antiarrhythmic drugs with insufficient symptom relief or rate regulation or adverse effects before ablation was considered. The patients were divided into two groups on the basis of the results of the first echocardiographic examination an average of two days after the procedure since we thought it important to have comparable heart rates. Fifteen patients in group A had normal systolic left ventricular function (ejection fraction > 50%) and 14 in group B had impaired left ventricular function (ejection fraction < 50%). In group A two patients had valvar heart disease-one with an aortic valve prosthesis and one with a slight to moderate mitral regurgitation. In group B four patients had valvar heart disease-one had been operated on for an atrial septal defect, one had moderate mitral regurgitation, and two had a slight aortic stenosis. In group B eight patients (7) 51 (7) 43 (7) 50 (6) cm2 23 (5)* 30 (7) 23 (5) 28 (6) 24 (7) 27 (6) (5) 32 (11) 57 (6) 39 (11) 55 (5) (26) 81 (19) 78 (24) 86 (24) 76 (24) 86 (21) EPSS, E point to septal separation; ESVI, end systolic volume index; IVRT, isovolumetric relaxation time.
*P < 0-05, tP < 0 01, *P < 0 001 significant differences between the groups two days after ablation. IIP < 0-05, **P < 0-001 significant changes within groups. 262 group.bmj.com on November 9, 2017 -Published by http://heart.bmj.com/ Downloaded from Left ventricularfunction after radiofrequency ablation of atrioventricularjunction for atrialfibrillation 807 were needed to obtain complete heart block in 27 patients; a modification of conduction through the atrioventricular junction made two of the patients dependent on a pacemaker. Seventeen patients received ablation during permanent atrial fibrillation. The pacemaker used was DDD-R in one patient, VVI in six patients, and VVI-R in 22 . Postoperative echocardiographic examinations did not disclose any signs of myocardial or valvar damage induced by ablation. One patient with a carotid artery stenosis and a history of previous transient cerebral ischaemia had a cerebral embolus without persistent neurological sequele on the day after the ablation, probably caused by decreased anticoagulation intensity.
CLINICAL FOLLOW UP
Four patients in each group were examined only twice. Three patients died, one of a cerebral tumour, one suddenly three months after the procedure, and the last of progressive heart failure. One patient did not have acceptable echo views and four patients were not accessible. The initial echocardiographic examination was performed 2 (1-8) days after ablation, and follow up examinations after 65 and 216 (130-339) days.
During follow up all patients remained in complete heart block. In group A nine patients had paroxysmal fibrillation at baseline, but during follow up underlying sinus rhythm was observed in only two patients. In group B all three patients with paroxysmal atrial fibrillation showed underlying atrial fibrillation during follow up. The DDD-R pacemaker in one patient had to be reprogrammed to VVI-R because the patient developed permanent atrial fibrillation.
ECHOCARDIOGRAPHIC FINDINGS DURING FOLLOW UP
The left atrium was significantly larger in patients in group B compared with those in group A at the initial examination (P < 0 05). The left atrial diameter was unchanged, but the area decreased in group B after the ablation (P < 0-05). The initial E point septal separation was also significantly larger in group B than in group A (P < 0 05). In group A no change was observed, but in group B a decrease was noted after the ablation (P < 0 05) (table 3). In 26 patients (90%) apical biplane volumes were obtained and in the remaining three single plane volumes. The end diastolic and end systolic volumes were significantly larger in group B at the initial examination (P < 0 05 and P < 0-01). In group A no significant changes in ejection fraction, end systolic, or end diastolic volumes were observed. In contrast, there was a significant (40%, P < 0.001) increase in ejection fraction after ablation in group B. There was a similar trend also for end systolic volume and end systolic volume index, but these changes were not significant (P = 0d13 and P = 007). End diastolic volume did not change after ablation ( figure  1, table 3 ). Individual data are given in figure  2 . There was a significant increase in stroke volume in group B (P < 0 05; figure 3, table   3 ).
There were no significant differences in Emax, E dec, or isovolumetric relaxation time between groups A and B at initial examination. No changes in Emax or isovolumetric relaxation time were observed after the procedure in either group. In both groups Edec increased in group A after 216 days and in group B after 65 days (P < 0 05) (figure 4, table 3). Individual data are given in figure 5 .
In group A mitral regurgitation was graded 0.5 ( 0 2) Atrial tachycardia itself has long been suggested as responsible for cardiac dilatation and progressive congestive heart failure. 16 In dogs paced at 190 beats/minute for three months left ventricular ejection fraction decreased from 49% to 29%." After termination of pacing left ventricular systolic function returned to normal within eight weeks. This was confirmed in another study on pigs paced at 240 beats/minute for three weeks. However, diastolic dysfunction still persisted four weeks after pacing had been stopped. '8 In newborn pigs three weeks of left atrial pacing tachycardia caused dilated cardiomyopathy. '9 Pharmacological control of ventricular rate in patients initially believed to have idiopathic dilated cardiomyopathy with secondary atrial fibrillation resulted in improvement in left ventricular function and complete resolution of symptoms of heart failure.' Thus, control of ventricular rate in our patients with drug resistant atrial fibrillation and impaired left ventricular function probably played an important part in improving their left ventricular function. Whether there is a relation between heart rate during arrhythmia and left ventricular dysfunction has to be evaluated in future studies.
Whether irregular heart rhythm in itself can cause impaired myocardial function is unclear. Recently Hariman et al reported the effect of regular ventricular pacing in anaesthetised dogs in which atrial fibrillation had been induced by rapid atrial pacing.20 During constant ventricular pacing at a rate similar to the ventricular response during fibrillation a small but significant increase of the cardiac output was observed. This phenomenon was more obvious at fast ventricular rate.
We do not believe that withdrawal of antiarrhythmic agents with negative inotropic effects was a major cause for the observed improvement in left ventricular function in our patients. Only one patient in the group with impaired left ventricular function was taking sotalol at the initial echocardiographic examinations, and he was not taking it at the following echocardiographic examinations. His left ventricular ejection fraction improved at both follow up examinations (43%, 51%, 60%). Six patients in group A and three in group B were initially taking amiodarone. When given orally, however, as in our patients, amiodarone is believed to have little if any negative inotropic action."
FACTORS INFLUENCING EJECTION FRACTION
Ejection fraction is dependent on several determinants. Dimensions, heart rate, type of atrial rhythm, synchronism, and age were sufficiently controlled for in this study. The study was not, however, designed to control for other important determinants of ejection fraction such as preload, afterload, contractility, and compliance. Thus we can only speculate about the reasons for the improvement in systolic left ventricular function. Left ventricular function improved in 11 of the 14 patients with initially impaired function. In one patient left ventricular function did not improve and in two patients it deteriorated. The patient in whom it was unchanged had dilated cardiomyopathy, chronic atrial fibrillation, and a mitral valve prosthesis. The two patients in whom deterioration was observed both had ischaemic heart disease and dilated cardiomyopathy; one also had chronic and the other paroxysmal atrial fibrillation. A lack of beneficial effect on left ventricular function in patients with concomitant ischaemic heart disease is in accordance with previous observations."' Thus, among patients with a low ejection fraction most benefited from the procedure. Improvement was observed in four out of five patients with an ejection fraction below 30%. 
